Founded November 2017
Stage Technology development
Investors The Trendlines Group, private investor
CEO Hagay Tzur
Note: Fucoxanthin (few-co-zan-then) is a brown pigment that occurs in the chloroplasts of brown algae.
AlgaHealth is developing new microalgal sources for fucoxanthin and novel cultivation and processing protocols for microalgae that will produce large quantities of natural, high-quality fucoxanthin at around 20% of the current costs. The company will develop and produce polysaccharides as a by-product, providing a second source of novel, high-value microalgal products.
AlgaHealth’s protocol will overcome current difficulties in producing microalgae by employing innovative microalgal physiological processes in order to maximize the quality and cost-efficiency of the production processes.
PCT, published 2017 for increasing cultivation and productivity in microalgae
Successful proof of concept and operating growing lab
Opportunity: With its innovative method for growing microalgae inland and novel microalgal strains, AlgaHealth will produce commercial levels of premium-quality fucoxanthin to address the large market demand for quality additives and to grab this extensive opportunity.
33 years’ management expertise in different industries, 18 years as a CEO; former CEO, Algatechnologies (8 years), where he turned the company from a losing enterprise into a world leader in the microalgae industry, to a $100 million exit; mentor and adviser for microalgae cultivation and research
20+ years’ experience in biotech; management positions in R&D and marketing; extensive experience with microalgae, including VP R&D at leading microalgae companies Algatechnologies and Algalo Industries; PhD, biology/chemistry, Weizmann Institute of Science; MBA, Bar-Ilan University; postdoctorate, Yale University
Fucoxanthin and polysaccharides are superfoods found in macro and microalgae that provide significant health and cosmetic benefits. Fucoxanthin supplements were shown to correct metabolic disorders (e.g., obesity, high glucose levels in the blood, insulin resistance) and to prevent cancer. Health applications for polysaccharides include as antiviral agents, ingredients for strengthening the immune system and reducing sugar/insulin levels, and as antioxidants and antiaging materials in cosmetics.
Today, the only source of fucoxanthin is marine macroalgae (seaweed). Yet, the low concentration levels of fucoxanthin in seaweed, combined with the limited seaweed supply, hinders fucoxanthin extraction at commercial levels.
The market for fucoxanthin was $600 million, with a CAGR of 6% (Global Fucoxanthin Market 2015 Industry Trend and Forecast 2020, QY Research 2015). Current prices for fucoxanthin range from $40 to $80 per gram (calculated for pure material).